Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC to crack down on ‘blatant disregard’ for FMD

The GPhC “will take action” if pharmacies are showing “blatant disregard” for FMD, the regulator’s director of inspection and fitness to practise Claire Bryce-Smith has said.

The General Pharmaceutical Council (GPhC) is continuing to monitor the use of falsified medicines directive (FMD) equipment during its inspections and will take action against pharmacies flagrantly failing to comply with the legislation.

This is according to a statement made by Ms Bryce-Smith in a video addressing the annual Sigma conference in Cebu, the Philippines on Tuesday (February 18).

Although the number of pharmacies registered with UK verification system SecurMed has increased to “well over” 12,000, there is “quite a difference between the numbers that have got the equipment in place and those who are actually using [it] routinely,” she said.

The regulator will work with the Medicines and Healthcare products Regulatory Agency (MHRA) to jointly “consider whether enforcement action should be taken” against pharmacies where FMD is not being used, Ms Bryce-Smith added. 

Pharmacies that show “absolutely no evidence” of implementing FMD, which includes registering to provide the service and train staff, will risk action being taken against them, she explained.

The future of FMD had looked uncertain following the UK’s departure from the European Union, as it is an EU anti-counterfeit medicine legislation.

However, Ms Bryce-Smith confirmed that the directive will remain in place during the transition period.

On Monday (February 17) British Generic Manufacturers Association director general Warwick Smith, also speaking at the Sigma conference, criticised FMD – saying it had reduced manufacturing capacity by 10%.

Is your pharmacy fully compliant with FMD legislation?

Related Content

Topics

         
Lead Pharmacist
Stoke-on-Trent
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel